XML 22 R7.htm IDEA: XBRL DOCUMENT v3.8.0.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
12 Months Ended
Dec. 30, 2017
Dec. 31, 2016
Jan. 02, 2016
CASH FLOWS FROM OPERATING ACTIVITIES:      
Net income $ 444,294 $ 209,794 $ 167,518
Adjustments to reconcile net income to net cash provided by operating activities:      
Depreciation and amortization 377,877 421,371 399,247
Gain on disposal of property and equipment, net (3,684) (6,265) (2,010)
Tangible asset impairment charges 1,807 125 6,293
Loss on extinguishment of debt   53,632  
Amortization of deferred financing costs 5,725 7,252 13,261
Amortization of Senior Notes original issue premium   (1,664) (3,330)
Insurance proceeds related to operating activities   10,499 23,243
Insurance benefit in net income   (10,499) (20,083)
Deferred tax (benefit) provision (122,928) (80,434) 17,606
Share-based compensation expense 20,532 18,355 15,832
Provision for doubtful accounts 17,999 11,112 12,103
Changes in operating assets and liabilities, net of business acquisitions:      
(Increase) decrease in receivables (67,001) 21,555 9,600
Decrease (increase) in inventories 40,403 (100,579) (55,047)
(Increase) decrease in prepaid expenses and other assets (23,882) 6,199 (20,716)
Increase (decrease) in accounts payable and bank checks outstanding 16,570 131,044 (71,448)
Increase (decrease) in accrued expenses and other liabilities 40,735 (135,855) 63,699
Net cash provided by operating activities 748,447 555,642 555,768
CASH FLOWS FROM INVESTING ACTIVITIES:      
Acquisition of businesses—net of cash (182,210) (122,294) (69,481)
Proceeds from sales of property and equipment 25,521 16,827 5,048
Purchases of property and equipment (221,281) (164,395) (187,409)
Investment in Avero, LLC   (7,658)  
Investment in marketable securities   (484,624)  
Insurance proceeds related to investing activities     2,771
Proceeds from redemption of industrial revenue bonds 22,139    
Purchase of industrial revenue bonds     (22,139)
Net cash used in investing activities (355,831) (762,144) (271,210)
CASH FLOWS FROM FINANCING ACTIVITIES:      
Proceeds from debt borrowings 2,549,982 2,706,535 22,139
Proceeds from debt refinancing   2,213,803  
Principal payments on debt and capital leases (2,650,157) (4,140,760) (109,489)
Repayment of industrial revenue bonds (22,139)    
Redemption of Old Senior Notes   (1,376,927)  
Payment for debt financing costs and fees (1,477) (25,941) (3,573)
Net proceeds from initial public offering   1,113,799  
Cash distribution to shareholders   (666,332)  
Contingent consideration paid for business acquisitions (6,375)    
Proceeds from employee share purchase plan 15,810 3,354  
Proceeds from exercise of stock options 18,386    
Tax withholding payments for net share-settled equity awards (28,293)    
Proceeds from common stock sales   2,850 500
Common stock repurchased (280,000)    
Common stock and share-based awards settled (594) (10,591) (19,992)
Net cash used in financing activities (404,857) (180,210) (110,415)
NET (DECREASE) INCREASE IN CASH AND CASH EQUIVALENTS (12,241) (386,712) 174,143
CASH AND CASH EQUIVALENTS—Beginning of year 131,090 517,802 343,659
CASH AND CASH EQUIVALENTS—End of year 118,849 131,090 517,802
SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION:      
Interest (net of amounts capitalized) 158,310 222,742 345,732
Income taxes paid—net 11,127 4,571 7,861
NON-CASH INVESTING AND FINANCING ACTIVITIES      
Property and equipment purchases included in accounts payable 30,664 50,349 26,885
Capital lease additions 91,149 80,118 $ 110,097
Cashless exercise of equity awards 30,136    
Contingent consideration payable for acquisition of businesses $ 4,200 8,375  
Marketable securities transferred in connection with the legal defeasance of the CMBS Fixed Loan Facility   484,624  
CMBS Fixed Loan Facility defeasance   471,615  
Restricted cash transferred to cash and cash equivalents   $ 6,147